
Substantial strides have been made in the management of Ph+ ALL.

Substantial strides have been made in the management of Ph+ ALL.

The role of monoclonal antibodies in minimizing COVID-19–related complications remains important to assess.

A retrospective analysis presents unique results for AML treatment.